Skip to main content
Market intelligence
EVMNSector not reported

Evommune, Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 22, 2026Jeegar Pravinkumar PatelChief Scientific OfficerSale1,488$22.50$33,480
Jun 22, 2026Janice Suzann DrewChief of Dev. OperationsSale20,000$22.63$452,600
Jun 22, 2026Luis C. PenaPresident & CEOSale7,438$22.71$168,917